CD44 expression
|
RCC
|
CD44 expression
|
RCC
|
sunitinib Resistant: C3 – Early Trials
|
sunitinib Resistant: C3 – Early Trials
|
CD44 expression
|
NSCLC
|
CD44 expression
|
NSCLC
|
PD1 inhibitor Sensitive: C3 – Early Trials
|
PD1 inhibitor Sensitive: C3 – Early Trials
|
CD44 expression
|
Gastric Cancer
|
CD44 expression
|
Gastric Cancer
|
trastuzumab Resistant: D – Preclinical
|
trastuzumab Resistant: D – Preclinical
|